Table 1: Patients treated with metastases in the nasal cavity and paranasal sinuses.
Sex/age | Primary tumor | Histology | Metastasis | Signs/symptoms | Treatment | Survival |
Male: 52 | Kidney | Clear cell adenocarcinoma | Maxillary sinus | Nasal obstruction epistaxis | Radiotheraphy + quimiotherapy | 12 months |
Female: 42 | Endometrium | Adenocarcinoma | Frontal sinus | Tumor | Radiotheraphy | 7 months |
Female: 49 | Cervix | Squamous cell carcinoma | Sphenoid sinus/clivus | Dysphonia/dysglusia | Radiotheraphy | 16 months |
Male: 61 | Liver | Hepatocarcinoma | Maxillary sinus | Nasal obstruction | Radiotheraphy | 12 months |
Male: 62 | Kidney | Clear cell adenocarcinoma | Nasal septum | Epistaxis | Endoscopic surgery | 30 months |
Male: 5 | Abdomen | Neuroblastoma | Sphenoid sinus | Hallazgo RMN | Endoscopic surgery | 4 months |
Male: 65 | Kidney | Clear cell adenocarcinoma | Maxillary sinus/ethmoid | Nasal obstruction epistaxis | Radiotheraphy + quimiotherapy | 48 months |
Male: 62 | Kidney | Clear cell adenocarcinoma | Lower turbinate | Nasal obstruction epistaxis | Endoscopic surgery | 12 months |